GB/T 38496-2020 in English
VALIDToxicological procedures and methods of safety evaluation for disinfectant
- Issued on:2020-03-06
- Implemented on:2020-10-01
- File Format:PDF
- Delivery:Via email within 5 business days
$650.00
《GB/T 38496-2020消毒剂安全性毒理学评价程序和方法》由628(国家疾病预防控制局)归口,主管部门为国家疾病预防控制局。
Introduction
Overview of the core content of the standard
This standard specifies the four-stage system approach for the toxicological evaluation of the safety of disinfectants:
| Stage | Test items | Key indicators |
|---|---|---|
| Stage I | Acute oral/inhalation toxicity, skin irritation, etc. | LD50/LC50, irritation index |
| Stage II | Subacute toxicity, mutagenicity test | Maximum no observed adverse effect level |
| Stage III | Subchronic toxicity, teratogenicity test | Developmental toxicity assessment |
| Phase IV | Chronic toxicity and carcinogenicity tests | Tumor incidence |
Key technical points
1. Experimental design principles
Determine the required and additional items according to the use scenario of the disinfectant:
- Air disinfectant: It is necessary to add acute inhalation toxicity (6.2) and eye irritation tests (6.4)
- Skin disinfectant: Select intact/broken skin irritation test according to the contact frequency (6.3)
- New disinfectant: It is necessary to complete three types of mutagenicity tests (6.8)
2. Key test methods
Acute oral toxicity test (6.1)
LD50 is calculated by the probability unit-logarithmic graphical method. The classification standard is:
| LD50(mg/kg) | Toxicity classification |
|---|---|
| ≥5000 | Practically non-toxic |
| 500-5000 | Low toxicity |
| 50-500 | Moderate toxicity |
| 1-50 | High toxicity |
| <1 | Highly toxic |
Implementation recommendations
Company compliance path
- Material preparation: Provide complete disinfectant formula and physicochemical properties (5.2)
- Project planning: Determine the test combination according to product use in accordance with clause 4.3
- Risk control: When LC50<1000mg/m³, a warning needs to be added to the product instructions (7.1.2)
Handling of special situations
For two-component packaged disinfectants, they should be mixed according to the instructions for use and tested as prototype samples (5.3). The test concentration of mucous membrane disinfectants should be 5 times the use concentration (5.4).

Loading PDF document...
Error loading PDF. Please make sure the file is valid and try again.
We also recommend
-

GB/T 26367-2020 in English
Hygienic requirements for biguanides disinfectants
2020-06-02 -

GB 19193-2015 in English
General principle on disinfection for infectious focus
2015-06-02 -

GB/T 33417-2016 in English
Test method of biological indicator for hydrogen peroxide vapour sterilization processes
2016-12-30 -

GB 38456-2020 in English
Hygienic requirements for antibacterial and bacteriostatic lotion
2020-11-17 -

GB/T 38497-2020 in English
Evaluation method of endoscopic disinfection effect
2020-03-06